Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Head and Neck Neoplasms | 65 | 2022 | 2694 | 7.530 |
Why?
|
Mouth Neoplasms | 18 | 2021 | 620 | 5.150 |
Why?
|
Carcinoma, Squamous Cell | 39 | 2022 | 4020 | 4.030 |
Why?
|
Tongue Neoplasms | 8 | 2021 | 179 | 3.770 |
Why?
|
Otolaryngology | 14 | 2022 | 640 | 2.700 |
Why?
|
Oropharyngeal Neoplasms | 10 | 2022 | 445 | 2.250 |
Why?
|
Lingual Nerve | 3 | 2019 | 32 | 1.970 |
Why?
|
Papillomavirus Infections | 13 | 2022 | 1472 | 1.960 |
Why?
|
Otorhinolaryngologic Surgical Procedures | 8 | 2021 | 329 | 1.830 |
Why?
|
Tongue | 9 | 2021 | 404 | 1.740 |
Why?
|
Salivary Gland Neoplasms | 3 | 2020 | 295 | 1.730 |
Why?
|
Surgical Flaps | 16 | 2021 | 1627 | 1.520 |
Why?
|
Oral Surgical Procedures | 2 | 2021 | 162 | 1.380 |
Why?
|
Reconstructive Surgical Procedures | 12 | 2021 | 2151 | 1.290 |
Why?
|
Glossectomy | 5 | 2021 | 52 | 1.250 |
Why?
|
Deglutition Disorders | 4 | 2021 | 565 | 1.130 |
Why?
|
Hypoglossal Nerve | 2 | 2016 | 96 | 1.110 |
Why?
|
Papillomaviridae | 7 | 2022 | 1131 | 1.080 |
Why?
|
Mouth | 4 | 2021 | 413 | 1.070 |
Why?
|
Tracheal Stenosis | 2 | 2017 | 224 | 1.030 |
Why?
|
Neck Dissection | 4 | 2019 | 214 | 0.910 |
Why?
|
Laryngeal Neoplasms | 4 | 2018 | 531 | 0.870 |
Why?
|
African Americans | 7 | 2019 | 5194 | 0.850 |
Why?
|
Ultrasonography | 6 | 2021 | 5913 | 0.850 |
Why?
|
Larynx, Artificial | 2 | 2020 | 68 | 0.840 |
Why?
|
Cross Infection | 2 | 2020 | 1411 | 0.820 |
Why?
|
Laryngoplasty | 1 | 2020 | 51 | 0.810 |
Why?
|
Alphapapillomavirus | 3 | 2022 | 223 | 0.800 |
Why?
|
Marital Status | 2 | 2019 | 443 | 0.780 |
Why?
|
Speech Disorders | 1 | 2021 | 182 | 0.770 |
Why?
|
Ranula | 1 | 2019 | 11 | 0.760 |
Why?
|
Tracheostomy | 2 | 2020 | 404 | 0.760 |
Why?
|
Sexual Behavior | 3 | 2019 | 1866 | 0.740 |
Why?
|
Papillomavirus Vaccines | 4 | 2022 | 480 | 0.740 |
Why?
|
Free Tissue Flaps | 3 | 2021 | 279 | 0.730 |
Why?
|
Survivors | 4 | 2018 | 2141 | 0.730 |
Why?
|
Salivary Glands | 1 | 2020 | 233 | 0.730 |
Why?
|
Marketing of Health Services | 1 | 2020 | 157 | 0.720 |
Why?
|
Humans | 179 | 2022 | 709431 | 0.700 |
Why?
|
Reimbursement, Incentive | 3 | 2020 | 525 | 0.700 |
Why?
|
Scalp | 4 | 2016 | 375 | 0.670 |
Why?
|
Neoplasm Staging | 12 | 2021 | 11244 | 0.670 |
Why?
|
Cost Control | 1 | 2020 | 628 | 0.650 |
Why?
|
Patient Advocacy | 1 | 2019 | 352 | 0.640 |
Why?
|
Tracheotomy | 1 | 2018 | 167 | 0.640 |
Why?
|
Infectious Disease Transmission, Patient-to-Professional | 1 | 2020 | 258 | 0.630 |
Why?
|
Medicare | 7 | 2021 | 5616 | 0.630 |
Why?
|
State Government | 1 | 2020 | 368 | 0.630 |
Why?
|
Insurance Coverage | 5 | 2020 | 1846 | 0.620 |
Why?
|
Access to Information | 1 | 2020 | 307 | 0.620 |
Why?
|
SEER Program | 10 | 2022 | 1556 | 0.610 |
Why?
|
Neoplasms, Multiple Primary | 2 | 2018 | 631 | 0.600 |
Why?
|
Mouth Mucosa | 2 | 2018 | 432 | 0.590 |
Why?
|
Orbit | 3 | 2006 | 430 | 0.570 |
Why?
|
Oropharynx | 1 | 2016 | 131 | 0.570 |
Why?
|
Nose Neoplasms | 4 | 2021 | 249 | 0.570 |
Why?
|
Analgesics, Opioid | 3 | 2021 | 3301 | 0.560 |
Why?
|
Cytodiagnosis | 1 | 2019 | 414 | 0.560 |
Why?
|
Postoperative Complications | 9 | 2021 | 15035 | 0.540 |
Why?
|
Temporal Bone | 5 | 2008 | 669 | 0.540 |
Why?
|
Retrospective Studies | 46 | 2022 | 71151 | 0.540 |
Why?
|
Middle Aged | 81 | 2022 | 215428 | 0.540 |
Why?
|
Colorectal Neoplasms, Hereditary Nonpolyposis | 1 | 2018 | 373 | 0.540 |
Why?
|
Aged | 67 | 2022 | 162592 | 0.530 |
Why?
|
Male | 95 | 2022 | 351848 | 0.520 |
Why?
|
Mandible | 2 | 2014 | 712 | 0.520 |
Why?
|
Conflict of Interest | 1 | 2019 | 564 | 0.520 |
Why?
|
Salvage Therapy | 4 | 2021 | 1298 | 0.510 |
Why?
|
Health Status Disparities | 2 | 2015 | 1723 | 0.510 |
Why?
|
Biopsy, Fine-Needle | 1 | 2019 | 1063 | 0.500 |
Why?
|
Pain, Postoperative | 2 | 2021 | 1598 | 0.500 |
Why?
|
Cross-Sectional Studies | 14 | 2021 | 22944 | 0.500 |
Why?
|
Myoblasts | 2 | 2006 | 263 | 0.490 |
Why?
|
Ambulatory Care Facilities | 1 | 2020 | 879 | 0.490 |
Why?
|
Coronavirus Infections | 3 | 2020 | 3163 | 0.490 |
Why?
|
Deglutition | 3 | 2021 | 195 | 0.490 |
Why?
|
Pneumonia, Viral | 3 | 2020 | 3276 | 0.480 |
Why?
|
Surgery, Computer-Assisted | 1 | 2021 | 1020 | 0.480 |
Why?
|
Thyroid Cartilage | 4 | 2004 | 40 | 0.480 |
Why?
|
Female | 91 | 2022 | 377269 | 0.470 |
Why?
|
United States | 33 | 2022 | 67177 | 0.450 |
Why?
|
Laryngectomy | 5 | 2020 | 234 | 0.450 |
Why?
|
Inpatients | 2 | 2022 | 2183 | 0.450 |
Why?
|
Cause of Death | 3 | 2018 | 3563 | 0.440 |
Why?
|
Microsurgery | 3 | 2009 | 814 | 0.440 |
Why?
|
Ophthalmologic Surgical Procedures | 2 | 2006 | 338 | 0.440 |
Why?
|
Jugular Veins | 2 | 2021 | 219 | 0.430 |
Why?
|
Drug Industry | 1 | 2019 | 908 | 0.430 |
Why?
|
Quality of Life | 8 | 2021 | 11553 | 0.430 |
Why?
|
Craniotomy | 1 | 2016 | 723 | 0.430 |
Why?
|
Medicaid | 4 | 2020 | 2599 | 0.420 |
Why?
|
Anemia | 2 | 2019 | 1383 | 0.420 |
Why?
|
Skull | 1 | 2016 | 808 | 0.420 |
Why?
|
Ear Neoplasms | 3 | 2008 | 123 | 0.410 |
Why?
|
Pandemics | 3 | 2020 | 6922 | 0.410 |
Why?
|
Life Expectancy | 1 | 2017 | 1119 | 0.410 |
Why?
|
Awareness | 1 | 2015 | 600 | 0.410 |
Why?
|
Neoplasm Recurrence, Local | 10 | 2021 | 8864 | 0.400 |
Why?
|
Frozen Sections | 3 | 2020 | 170 | 0.400 |
Why?
|
Trachea | 2 | 2015 | 1073 | 0.390 |
Why?
|
Academic Medical Centers | 1 | 2021 | 2785 | 0.390 |
Why?
|
Neoplasms, Second Primary | 2 | 2018 | 1010 | 0.390 |
Why?
|
Survival Analysis | 8 | 2018 | 10603 | 0.380 |
Why?
|
Lip | 2 | 2009 | 182 | 0.370 |
Why?
|
Skull Base Neoplasms | 3 | 2008 | 276 | 0.370 |
Why?
|
Carcinoma, Adenoid Cystic | 5 | 2022 | 262 | 0.360 |
Why?
|
Adult | 54 | 2021 | 212298 | 0.360 |
Why?
|
Disease-Free Survival | 8 | 2019 | 7078 | 0.350 |
Why?
|
Health Knowledge, Attitudes, Practice | 5 | 2022 | 3946 | 0.350 |
Why?
|
Surgical Wound Infection | 1 | 2018 | 1488 | 0.340 |
Why?
|
Preoperative Care | 1 | 2018 | 2368 | 0.340 |
Why?
|
Drug Prescriptions | 1 | 2018 | 1673 | 0.340 |
Why?
|
Aged, 80 and over | 29 | 2022 | 58752 | 0.330 |
Why?
|
Paranasal Sinus Neoplasms | 4 | 2021 | 241 | 0.330 |
Why?
|
Otorhinolaryngologic Diseases | 1 | 2008 | 93 | 0.330 |
Why?
|
Societies, Medical | 1 | 2019 | 3665 | 0.320 |
Why?
|
Opioid-Related Disorders | 1 | 2021 | 1825 | 0.320 |
Why?
|
Laryngostenosis | 2 | 2010 | 158 | 0.310 |
Why?
|
Prognosis | 11 | 2021 | 29148 | 0.310 |
Why?
|
Speech | 2 | 2021 | 483 | 0.300 |
Why?
|
Internship and Residency | 4 | 2022 | 5527 | 0.300 |
Why?
|
Thyroid Neoplasms | 2 | 2018 | 2214 | 0.300 |
Why?
|
Bone Marrow Cells | 1 | 2014 | 2631 | 0.300 |
Why?
|
Neoplasms | 6 | 2022 | 20421 | 0.300 |
Why?
|
Stents | 2 | 2017 | 3299 | 0.290 |
Why?
|
Nasal Cavity | 4 | 2021 | 308 | 0.290 |
Why?
|
Patient Protection and Affordable Care Act | 3 | 2020 | 1160 | 0.290 |
Why?
|
Orbital Diseases | 1 | 2006 | 191 | 0.260 |
Why?
|
Radiotherapy, Adjuvant | 6 | 2020 | 1832 | 0.260 |
Why?
|
Orbit Evisceration | 1 | 2003 | 11 | 0.260 |
Why?
|
Microcirculation | 1 | 2009 | 1292 | 0.260 |
Why?
|
Alcohol Drinking | 1 | 2017 | 3869 | 0.260 |
Why?
|
Sex Factors | 6 | 2019 | 10744 | 0.250 |
Why?
|
Treatment Outcome | 18 | 2021 | 61963 | 0.250 |
Why?
|
Intensive Care Units | 1 | 2017 | 3422 | 0.250 |
Why?
|
Pilot Projects | 4 | 2021 | 8036 | 0.250 |
Why?
|
Coloring Agents | 2 | 2021 | 557 | 0.250 |
Why?
|
Rectus Abdominis | 1 | 2003 | 97 | 0.250 |
Why?
|
Reimbursement Mechanisms | 2 | 2020 | 663 | 0.240 |
Why?
|
Carcinoma, Basal Cell | 5 | 2008 | 515 | 0.240 |
Why?
|
Receptors, Antigen, T-Cell, gamma-delta | 3 | 2013 | 344 | 0.240 |
Why?
|
Laryngeal Diseases | 2 | 2020 | 246 | 0.240 |
Why?
|
Depressive Disorder, Major | 2 | 2019 | 4470 | 0.230 |
Why?
|
Phonation | 2 | 2020 | 212 | 0.230 |
Why?
|
Fistula | 3 | 2012 | 213 | 0.230 |
Why?
|
Delivery of Health Care | 1 | 2020 | 4747 | 0.230 |
Why?
|
Skin Neoplasms | 4 | 2016 | 5349 | 0.230 |
Why?
|
Neoplasm Invasiveness | 6 | 2020 | 3740 | 0.220 |
Why?
|
Forearm | 4 | 2016 | 408 | 0.220 |
Why?
|
Fascia | 2 | 2000 | 134 | 0.220 |
Why?
|
Communication | 1 | 2016 | 3395 | 0.220 |
Why?
|
Bone Neoplasms | 1 | 2014 | 2568 | 0.220 |
Why?
|
Facial Neoplasms | 2 | 2002 | 131 | 0.220 |
Why?
|
Rats, Wistar | 2 | 2016 | 2012 | 0.220 |
Why?
|
Reoperation | 4 | 2018 | 4155 | 0.220 |
Why?
|
Adenocarcinoma | 3 | 2018 | 6462 | 0.210 |
Why?
|
Eye Diseases | 1 | 2006 | 650 | 0.210 |
Why?
|
Cricoid Cartilage | 2 | 2015 | 73 | 0.210 |
Why?
|
Socioeconomic Factors | 4 | 2019 | 7740 | 0.210 |
Why?
|
Pharyngectomy | 1 | 2000 | 45 | 0.200 |
Why?
|
Parotid Neoplasms | 2 | 2019 | 161 | 0.200 |
Why?
|
Endocrine Surgical Procedures | 1 | 2020 | 30 | 0.200 |
Why?
|
Intraoperative Period | 2 | 2021 | 547 | 0.200 |
Why?
|
Prostheses and Implants | 3 | 2000 | 1330 | 0.200 |
Why?
|
Smoking | 2 | 2017 | 8940 | 0.200 |
Why?
|
Preoperative Period | 2 | 2021 | 556 | 0.200 |
Why?
|
Logistic Models | 5 | 2020 | 13622 | 0.200 |
Why?
|
Relative Value Scales | 1 | 2020 | 87 | 0.200 |
Why?
|
Postoperative Care | 3 | 2020 | 1513 | 0.200 |
Why?
|
Fee Schedules | 1 | 2020 | 87 | 0.200 |
Why?
|
Intubation | 1 | 2000 | 138 | 0.200 |
Why?
|
Risk Assessment | 6 | 2021 | 23519 | 0.200 |
Why?
|
Adenoviruses, Human | 2 | 2014 | 275 | 0.190 |
Why?
|
Epistaxis | 1 | 2000 | 109 | 0.190 |
Why?
|
CD8-Positive T-Lymphocytes | 4 | 2015 | 4282 | 0.190 |
Why?
|
Positron-Emission Tomography | 2 | 2013 | 6123 | 0.190 |
Why?
|
Sphenoid Bone | 1 | 2000 | 171 | 0.190 |
Why?
|
Toll-Like Receptor 8 | 3 | 2014 | 92 | 0.190 |
Why?
|
Neoplasm Metastasis | 4 | 2019 | 5168 | 0.190 |
Why?
|
Nose | 2 | 2020 | 487 | 0.190 |
Why?
|
Skull Neoplasms | 2 | 2007 | 177 | 0.190 |
Why?
|
Economics, Hospital | 1 | 2021 | 196 | 0.180 |
Why?
|
Mandibular Neoplasms | 1 | 2000 | 132 | 0.180 |
Why?
|
Young Adult | 13 | 2021 | 56163 | 0.180 |
Why?
|
Illinois | 1 | 2019 | 116 | 0.180 |
Why?
|
Prospective Payment System | 1 | 2020 | 135 | 0.180 |
Why?
|
Insurance, Health | 4 | 2020 | 2483 | 0.180 |
Why?
|
Cohort Studies | 10 | 2022 | 39650 | 0.180 |
Why?
|
Carcinoma, Mucoepidermoid | 1 | 2019 | 98 | 0.180 |
Why?
|
Research Report | 1 | 2022 | 358 | 0.170 |
Why?
|
Dissection | 2 | 2019 | 278 | 0.170 |
Why?
|
Momordica charantia | 1 | 2017 | 6 | 0.170 |
Why?
|
4-Nitroquinoline-1-oxide | 1 | 2017 | 18 | 0.170 |
Why?
|
Managed Competition | 1 | 2018 | 34 | 0.170 |
Why?
|
Tomography, X-Ray Computed | 6 | 2021 | 20307 | 0.170 |
Why?
|
Multivariate Analysis | 3 | 2018 | 12517 | 0.170 |
Why?
|
Immune System Phenomena | 1 | 2017 | 16 | 0.170 |
Why?
|
Lymphocytes, Tumor-Infiltrating | 2 | 2015 | 1088 | 0.170 |
Why?
|
Phototherapy | 1 | 2021 | 344 | 0.170 |
Why?
|
Nasal Mucosa | 1 | 2021 | 368 | 0.170 |
Why?
|
Carotid Artery, Common | 2 | 2009 | 191 | 0.170 |
Why?
|
Surgical Wound Dehiscence | 1 | 2019 | 214 | 0.170 |
Why?
|
Vocal Cord Paralysis | 3 | 2000 | 250 | 0.170 |
Why?
|
Mi-2 Nucleosome Remodeling and Deacetylase Complex | 1 | 2018 | 104 | 0.170 |
Why?
|
Hematocrit | 1 | 2019 | 639 | 0.170 |
Why?
|
Carotid Artery, Internal | 1 | 2000 | 474 | 0.160 |
Why?
|
Models, Educational | 1 | 2020 | 396 | 0.160 |
Why?
|
Outpatient Clinics, Hospital | 1 | 2020 | 413 | 0.160 |
Why?
|
CD4-Positive T-Lymphocytes | 4 | 2015 | 4402 | 0.160 |
Why?
|
Skin Transplantation | 2 | 2000 | 1128 | 0.160 |
Why?
|
Regression Analysis | 3 | 2017 | 6515 | 0.160 |
Why?
|
Aerosols | 1 | 2020 | 692 | 0.160 |
Why?
|
Adenoidectomy | 1 | 2018 | 168 | 0.160 |
Why?
|
Specialties, Surgical | 1 | 2022 | 386 | 0.160 |
Why?
|
Immunization Schedule | 1 | 2018 | 221 | 0.160 |
Why?
|
Cutaneous Fistula | 2 | 2012 | 84 | 0.160 |
Why?
|
Financing, Government | 1 | 2021 | 484 | 0.160 |
Why?
|
Suicide | 2 | 2018 | 1559 | 0.160 |
Why?
|
Medically Uninsured | 2 | 2020 | 860 | 0.160 |
Why?
|
Dentigerous Cyst | 1 | 1996 | 21 | 0.160 |
Why?
|
Ambulatory Surgical Procedures | 1 | 2022 | 450 | 0.160 |
Why?
|
Maxillary Diseases | 1 | 1996 | 53 | 0.150 |
Why?
|
Regeneration | 1 | 2006 | 1550 | 0.150 |
Why?
|
Face | 2 | 2002 | 965 | 0.150 |
Why?
|
Liver Function Tests | 1 | 2018 | 537 | 0.150 |
Why?
|
Physician Incentive Plans | 1 | 2018 | 174 | 0.150 |
Why?
|
Esophagectomy | 1 | 2000 | 465 | 0.150 |
Why?
|
Plant Extracts | 2 | 2017 | 462 | 0.150 |
Why?
|
Facial Nerve | 1 | 1999 | 271 | 0.150 |
Why?
|
Survival Rate | 9 | 2021 | 13363 | 0.150 |
Why?
|
Odds Ratio | 3 | 2019 | 10019 | 0.150 |
Why?
|
Reference Standards | 1 | 2019 | 890 | 0.150 |
Why?
|
Granuloma, Laryngeal | 1 | 1995 | 8 | 0.150 |
Why?
|
Vaccination | 2 | 2018 | 2847 | 0.150 |
Why?
|
Age Factors | 4 | 2018 | 18954 | 0.150 |
Why?
|
Tonsillar Neoplasms | 1 | 1996 | 54 | 0.150 |
Why?
|
Mastication | 1 | 2015 | 49 | 0.150 |
Why?
|
Blood Chemical Analysis | 1 | 2018 | 467 | 0.140 |
Why?
|
Adolescent | 19 | 2020 | 85327 | 0.140 |
Why?
|
Fluorodeoxyglucose F18 | 3 | 2013 | 1994 | 0.140 |
Why?
|
Tonsillectomy | 1 | 2018 | 271 | 0.140 |
Why?
|
Kidney Function Tests | 1 | 2018 | 706 | 0.140 |
Why?
|
Neck Muscles | 1 | 2015 | 106 | 0.140 |
Why?
|
Granuloma, Foreign-Body | 1 | 1995 | 48 | 0.140 |
Why?
|
Databases, Factual | 5 | 2019 | 7801 | 0.140 |
Why?
|
Consensus Development Conferences as Topic | 1 | 2015 | 169 | 0.140 |
Why?
|
Thigh | 1 | 2016 | 233 | 0.140 |
Why?
|
Paranasal Sinus Diseases | 2 | 2012 | 130 | 0.140 |
Why?
|
Wrist | 1 | 1996 | 207 | 0.140 |
Why?
|
Rats | 5 | 2016 | 25068 | 0.140 |
Why?
|
Cell Line, Tumor | 11 | 2022 | 17087 | 0.140 |
Why?
|
T-Lymphocytes, Regulatory | 3 | 2013 | 3047 | 0.140 |
Why?
|
Rats, Inbred Lew | 3 | 2006 | 1154 | 0.140 |
Why?
|
Disease Transmission, Infectious | 1 | 2020 | 548 | 0.140 |
Why?
|
Laryngeal Nerves | 1 | 1994 | 59 | 0.130 |
Why?
|
Pharyngeal Muscles | 1 | 1994 | 73 | 0.130 |
Why?
|
Sexual Partners | 1 | 2019 | 688 | 0.130 |
Why?
|
Polytetrafluoroethylene | 1 | 1995 | 254 | 0.130 |
Why?
|
Spiral Ganglion | 1 | 2015 | 164 | 0.130 |
Why?
|
Cucurbitaceae | 1 | 2013 | 5 | 0.130 |
Why?
|
Office Visits | 1 | 2019 | 631 | 0.130 |
Why?
|
Neoplasms, Radiation-Induced | 1 | 2018 | 569 | 0.130 |
Why?
|
Betapapillomavirus | 1 | 2013 | 6 | 0.130 |
Why?
|
Proportional Hazards Models | 3 | 2019 | 12442 | 0.130 |
Why?
|
Fluorescent Dyes | 1 | 2022 | 1990 | 0.130 |
Why?
|
Hospitals, University | 1 | 2015 | 586 | 0.130 |
Why?
|
Prosthesis Design | 1 | 2020 | 2135 | 0.130 |
Why?
|
Carotid Artery Diseases | 1 | 2000 | 924 | 0.130 |
Why?
|
Adenovirus E1A Proteins | 1 | 2013 | 91 | 0.120 |
Why?
|
Hand Strength | 1 | 1996 | 450 | 0.120 |
Why?
|
Paralysis | 1 | 1994 | 234 | 0.120 |
Why?
|
Independent Living | 1 | 2017 | 530 | 0.120 |
Why?
|
Tumor Microenvironment | 5 | 2017 | 2963 | 0.120 |
Why?
|
Incidence | 4 | 2019 | 20587 | 0.120 |
Why?
|
Internationality | 1 | 2019 | 1001 | 0.120 |
Why?
|
Prevalence | 3 | 2019 | 14849 | 0.120 |
Why?
|
Down-Regulation | 3 | 2018 | 3125 | 0.120 |
Why?
|
Vascular Surgical Procedures | 1 | 2002 | 1509 | 0.120 |
Why?
|
Neck | 4 | 2021 | 697 | 0.120 |
Why?
|
Lymphoma | 1 | 2002 | 1908 | 0.120 |
Why?
|
Chondroblastoma | 1 | 1992 | 51 | 0.120 |
Why?
|
Fellowships and Scholarships | 1 | 2020 | 964 | 0.110 |
Why?
|
Risk-Taking | 1 | 2018 | 986 | 0.110 |
Why?
|
Delayed Diagnosis | 1 | 2015 | 410 | 0.110 |
Why?
|
Bone Resorption | 1 | 1996 | 747 | 0.110 |
Why?
|
Cranial Irradiation | 1 | 2015 | 436 | 0.110 |
Why?
|
Predictive Value of Tests | 2 | 2019 | 15316 | 0.110 |
Why?
|
Healthcare Disparities | 2 | 2018 | 2987 | 0.110 |
Why?
|
Oncolytic Virotherapy | 2 | 2014 | 442 | 0.110 |
Why?
|
Health Care Reform | 1 | 2021 | 1255 | 0.110 |
Why?
|
Incidental Findings | 3 | 2011 | 675 | 0.110 |
Why?
|
Oncogene Proteins, Viral | 1 | 2013 | 387 | 0.110 |
Why?
|
Lymphatic Metastasis | 1 | 2019 | 2992 | 0.110 |
Why?
|
Cannabis | 1 | 2016 | 326 | 0.100 |
Why?
|
Motivation | 1 | 2020 | 1866 | 0.100 |
Why?
|
Coculture Techniques | 4 | 2018 | 1382 | 0.100 |
Why?
|
Neurosurgical Procedures | 1 | 2002 | 1990 | 0.100 |
Why?
|
Case-Control Studies | 5 | 2022 | 21874 | 0.100 |
Why?
|
Intracranial Aneurysm | 1 | 2000 | 1335 | 0.100 |
Why?
|
Transcription Factors | 2 | 2022 | 11982 | 0.100 |
Why?
|
Cell Cycle Proteins | 1 | 2022 | 3513 | 0.100 |
Why?
|
Hospitalization | 2 | 2020 | 9632 | 0.100 |
Why?
|
Students, Medical | 1 | 2022 | 1734 | 0.100 |
Why?
|
Tissue Engineering | 3 | 2006 | 1846 | 0.100 |
Why?
|
Time Factors | 5 | 2021 | 41295 | 0.090 |
Why?
|
Antineoplastic Agents, Phytogenic | 1 | 2013 | 629 | 0.090 |
Why?
|
Registries | 3 | 2020 | 8019 | 0.090 |
Why?
|
Combined Modality Therapy | 4 | 2021 | 8941 | 0.090 |
Why?
|
Animals | 18 | 2020 | 170647 | 0.090 |
Why?
|
|